316 related articles for article (PubMed ID: 17042918)
1. Kynurenine pathway metabolism in patients with osteoporosis after 2 years of drug treatment.
Forrest CM; Mackay GM; Oxford L; Stoy N; Stone TW; Darlington LG
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1078-87. PubMed ID: 17042918
[TBL] [Abstract][Full Text] [Related]
2. Kynurenine and neopterin levels in patients with rheumatoid arthritis and osteoporosis during drug treatment.
Forrest CM; Kennedy A; Stone TW; Stoy N; Darlington LG
Adv Exp Med Biol; 2003; 527():287-95. PubMed ID: 15206742
[TBL] [Abstract][Full Text] [Related]
3. Altered kynurenine metabolism correlates with infarct volume in stroke.
Darlington LG; Mackay GM; Forrest CM; Stoy N; George C; Stone TW
Eur J Neurosci; 2007 Oct; 26(8):2211-21. PubMed ID: 17892481
[TBL] [Abstract][Full Text] [Related]
4. Associations between intake of fish and n-3 long-chain polyunsaturated fatty acids and plasma metabolites related to the kynurenine pathway in patients with coronary artery disease.
Karlsson T; Strand E; Dierkes J; Drevon CA; Øyen J; Midttun Ø; Ueland PM; Gudbrandsen OA; Pedersen ER; Nygård O
Eur J Nutr; 2017 Feb; 56(1):261-272. PubMed ID: 26482150
[TBL] [Abstract][Full Text] [Related]
5. Tryptophan metabolism and oxidative stress in patients with Huntington's disease.
Stoy N; Mackay GM; Forrest CM; Christofides J; Egerton M; Stone TW; Darlington LG
J Neurochem; 2005 May; 93(3):611-23. PubMed ID: 15836620
[TBL] [Abstract][Full Text] [Related]
6. Tryptophan metabolism and oxidative stress in patients with chronic brain injury.
Mackay GM; Forrest CM; Stoy N; Christofides J; Egerton M; Stone TW; Darlington LG
Eur J Neurol; 2006 Jan; 13(1):30-42. PubMed ID: 16420391
[TBL] [Abstract][Full Text] [Related]
7. Tryptophan loading induces oxidative stress.
Forrest CM; Mackay GM; Stoy N; Egerton M; Christofides J; Stone TW; Darlington LG
Free Radic Res; 2004 Nov; 38(11):1167-71. PubMed ID: 15621693
[TBL] [Abstract][Full Text] [Related]
8. Kynurenine metabolism predicts cognitive function in patients following cardiac bypass and thoracic surgery.
Forrest CM; Mackay GM; Oxford L; Millar K; Darlington LG; Higgins MJ; Stone TW
J Neurochem; 2011 Oct; 119(1):136-52. PubMed ID: 21819405
[TBL] [Abstract][Full Text] [Related]
9. A community-based study on determinants of circulating markers of cellular immune activation and kynurenines: the Hordaland Health Study.
Theofylaktopoulou D; Midttun Ø; Ulvik A; Ueland PM; Tell GS; Vollset SE; Nygård O; Eussen SJ
Clin Exp Immunol; 2013 Jul; 173(1):121-30. PubMed ID: 23607723
[TBL] [Abstract][Full Text] [Related]
10. A single-run liquid chromatography mass spectrometry method to quantify neuroactive kynurenine pathway metabolites in rat plasma.
Orsatti L; Speziale R; Orsale MV; Caretti F; Veneziano M; Zini M; Monteagudo E; Lyons K; Beconi M; Chan K; Herbst T; Toledo-Sherman L; Munoz-Sanjuan I; Bonelli F; Dominguez C
J Pharm Biomed Anal; 2015 Mar; 107():426-31. PubMed ID: 25668794
[TBL] [Abstract][Full Text] [Related]
11. Central kynurenine pathway shift with age in women.
de Bie J; Guest J; Guillemin GJ; Grant R
J Neurochem; 2016 Mar; 136(5):995-1003. PubMed ID: 26670548
[TBL] [Abstract][Full Text] [Related]
12. Hypothesis kynurenic and quinolinic acids: The main players of the kynurenine pathway and opponents in inflammatory disease.
Badawy AA
Med Hypotheses; 2018 Sep; 118():129-138. PubMed ID: 30037600
[TBL] [Abstract][Full Text] [Related]
13. Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy.
Ryan KM; Allers KA; McLoughlin DM; Harkin A
Brain Behav Immun; 2020 Jan; 83():153-162. PubMed ID: 31606477
[TBL] [Abstract][Full Text] [Related]
14. An exploratory study of the interplay between decreased concentration of tryptophan, accumulation of kynurenines, and inflammatory arthritis.
Kolodziej L
IUBMB Life; 2012 Dec; 64(12):983-7. PubMed ID: 23124849
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of toxic products degradation of kynurenine in hemodialyzed patients.
Pawlak D; Pawlak K; Malyszko J; Mysliwiec M; Buczko W
Int Urol Nephrol; 2001; 33(2):399-404. PubMed ID: 12092667
[TBL] [Abstract][Full Text] [Related]
16. New insights into tryptophan and its metabolites in the regulation of bone metabolism.
Michalowska M; Znorko B; Kaminski T; Oksztulska-Kolanek E; Pawlak D
J Physiol Pharmacol; 2015 Dec; 66(6):779-91. PubMed ID: 26769827
[TBL] [Abstract][Full Text] [Related]
17. Kynurenine Pathway Metabolites in Alzheimer's Disease.
Giil LM; Midttun Ø; Refsum H; Ulvik A; Advani R; Smith AD; Ueland PM
J Alzheimers Dis; 2017; 60(2):495-504. PubMed ID: 28869479
[TBL] [Abstract][Full Text] [Related]
18. Possible involvement of kynurenamines in the pathogenesis of cataract in diabetic patients.
Andrzejewska-Buczko J; Pawlak D; Tankiewicz A; Matys T; Buczko W
Med Sci Monit; 2001; 7(4):742-5. PubMed ID: 11433204
[TBL] [Abstract][Full Text] [Related]
19. LC-MS/MS-based quantification of kynurenine metabolites, tryptophan, monoamines and neopterin in plasma, cerebrospinal fluid and brain.
Fuertig R; Ceci A; Camus SM; Bezard E; Luippold AH; Hengerer B
Bioanalysis; 2016 Sep; 8(18):1903-17. PubMed ID: 27524289
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a single analytical method for the determination of tryptophan, and its kynurenine metabolites in rat plasma.
Möller M; Du Preez JL; Harvey BH
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jun; 898():121-9. PubMed ID: 22608808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
